|
Flu Hospitalizations Soar as Triple Viral Threat Looms ahead of Holidays
Nearly every US state is battling high levels of flu-like illness, public health authorities warned as multiple respiratory viruses threaten to overwhelm the health care system while people travel for the holidays and gather indoors with friends and family. Continue reading
Value-Based Payment Models May Help Curb High Healthcare Spending
According to a Health Affairs research brief, as healthcare spending escalates in the US, stakeholders have started looking at value-based payment models to address rising costs, but many payments are still tied to fee-for-service models. Read more
Study Finds Myocarditis after Covid Vaccine Low Among Teens and Young Adults
The incidence of myocarditis and pericarditis after Covid vaccination is low and most patients make a full recovery, a large international study from Nationwide Children’s Hospital found. Most of the cases occurred in male teens and young adults and usually after the second dose of a primary series of either the Pfizer-BioNTech or Moderna vaccine. Read more
UTHSA Has Initiated an NIH Multicenter Trial of the ACTG for Human Mpox Virus
UT Health San Antonio has initiated the STOMP (Study of Tecoviramat for Human Monkeypox Virus), an NIH multicenter trial of the ACTG. It is a randomized, placebo-controlled, double-blinded trail of the safety and efficacy of tecovirimat for Mpox. Those with severe disease will quality for open label drug. For this trial, any patient with suspect or confirmed Mpox can be referred to Dr. Tom Patterson, patterson@uthscsa.edu or Dr. Ruth Serrano, serranopinil@uthscsa.edu to evaluate for the study, or call 210-567-5262.
|
